These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8835883)

  • 21. Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study.
    Van Gool WA; Weinstein HC; Scheltens P; Walstra GJ
    Lancet; 2001 Aug; 358(9280):455-60. PubMed ID: 11513909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
    Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
    Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.
    Xiao S; Wang T; Ma X; Qin Y; Li X; Zhao Z; Liu X; Wang X; Xie H; Jiang Q; Sun L; Luo B; Shang L; Chen W; Bai Y; Tang M; He M; Wu L; Ma Q; Hou D; He J
    Age Ageing; 2017 Sep; 46(5):767-773. PubMed ID: 28419192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoids in Alzheimer's disease. The story so far.
    Aisen PS; Pasinetti GM
    Drugs Aging; 1998 Jan; 12(1):1-6. PubMed ID: 9467682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily.
    De Diego JI; Prim MP; De Sarriá MJ; Madero R; Gavilán J
    Laryngoscope; 1998 Apr; 108(4 Pt 1):573-5. PubMed ID: 9546272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The distribution of alpha 1-antichymotrypsin and amyloid production in the brain in Alzheimer's disease.
    Miyakawa T; Katsuragi S; Yamashita K; Araki K; Hashimura T; Kimura T; Ohuchi K
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 61(5):331-5. PubMed ID: 1348895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease.
    Novak P; Schmidt R; Kontsekova E; Kovacech B; Smolek T; Katina S; Fialova L; Prcina M; Parrak V; Dal-Bianco P; Brunner M; Staffen W; Rainer M; Ondrus M; Ropele S; Smisek M; Sivak R; Zilka N; Winblad B; Novak M
    Alzheimers Res Ther; 2018 Oct; 10(1):108. PubMed ID: 30355322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.
    Egan MF; Kost J; Tariot PN; Aisen PS; Cummings JL; Vellas B; Sur C; Mukai Y; Voss T; Furtek C; Mahoney E; Harper Mozley L; Vandenberghe R; Mo Y; Michelson D
    N Engl J Med; 2018 May; 378(18):1691-1703. PubMed ID: 29719179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.
    Potter H; Wefes IM; Nilsson LN
    Neurobiol Aging; 2001; 22(6):923-30. PubMed ID: 11755000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.
    Abraham CR; Selkoe DJ; Potter H
    Cell; 1988 Feb; 52(4):487-501. PubMed ID: 3257719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease?
    Furby A; Leys D; Delacourte A; Buee L; Soetaert G; Petit H
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):469. PubMed ID: 1713952
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of inflammatory reaction in Alzheimer's disease and neurodegenerative processes].
    Członkowska A; Kurkowska-Jastrzebska I
    Neurol Neurochir Pol; 2002; 36(1):15-23. PubMed ID: 12053606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nontapering versus tapering prednisone in acute exacerbations of asthma: a pilot trial.
    Verbeek PR; Geerts WH
    J Emerg Med; 1995; 13(5):715-9. PubMed ID: 8530798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
    Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
    PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
    Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM
    N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galanthamine treatment in Alzheimer's disease.
    Dal-Bianco P; Maly J; Wôber C; Lind C; Koch G; Hufgard J; Marschall I; Mraz M; Deecke L
    J Neural Transm Suppl; 1991; 33():59-63. PubMed ID: 1753253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: a randomized, double-masked, placebo-controlled trial. Metrifonate Study Group.
    Jann MW; Cyrus PA; Eisner LS; Margolin DI; Griffin T; Gulanski B
    Clin Ther; 1999 Jan; 21(1):88-102. PubMed ID: 10090427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease.
    Abraham CR; Potter H
    Ann Med; 1989; 21(2):77-81. PubMed ID: 2669847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous nicotine in Alzheimer's disease: a pilot study.
    Newhouse PA; Sunderland T; Tariot PN; Blumhardt CL; Weingartner H; Mellow A; Murphy DL
    Psychopharmacology (Berl); 1988; 95(2):171-5. PubMed ID: 3137593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo-controlled trial of prednisone in advanced HIV-1 infection.
    McComsey GA; Whalen CC; Mawhorter SD; Asaad R; Valdez H; Patki AH; Klaumunzner J; Gopalakrishna KV; Calabrese LH; Lederman MM
    AIDS; 2001 Feb; 15(3):321-7. PubMed ID: 11273211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.